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Background: HIV testing among tuberculosis (TB) patients is
critical in improving morbidity and mortality, as those found to be
HIV positive will be offered a continuum of care including ART, if
indicated.In Tanzania, the TB/HIV collaborative activities started in
2006, however, the complex interaction between the dual HIV and
TB in children in Tanzania is still underreported.
We conducted this study with the aim to determine prevalence
of TB/HIV co-infection in children; trend of HIV testing among chil-
dren with TB; and association of HIV and TB infections in children.
Methods & Materials: We conducted a retrospective review of
data involving children below 15 years enrolled in the TB clinics
between 2006 and 2010 in selected four regions in Tanzania. All
children on TB treatment were eligible.
Results: A total of 4,684 TB conﬁrmed children were reviewed
with the mean age of 6.2± 4.2 years. Almost half 2284 (48.4%) of
themwere tested for HIV. The prevalence of HIV among the TB con-
ﬁrmed children was 905 (39.6%). The prevalence of HIV increased
from 230 (22%) in 2006 to 270 (44%) in 2009 then dropped to 255
(37%) in 2010 and the changes were signiﬁcant (p<0.05). The pro-
portion of children tested for HIV among TB patients increased
signiﬁcantly from104 (25%) in 2006 to 671 (93%) in 2010 (p=0.001).
The <5 years had lower risk of HIV infection [Odds ratio (OR) = 0.8;
95% Conﬁdence Interval (CI): 0.7 – 1.0]. HIV positive children had
higher risk of developing EPTB [OR=1.4; 95% CI: 1.2-1.7]. HIV pos-
itivity was statistically associated with TB treatment failure [OR=
1.4, 95%CI: 1.0-2.0], TB relapse [OR= 2.5, 95%CI: 1.5-4.3] as well as
increased risk of death rate among TB pediatric children [OR= 2.1,
95%CI: 1.4-3.1]
Conclusion: There has been a signiﬁcant increase in HIV testing
rate with years as well as increased prevalence of HIV among TB
children. HIV infection among TB patients is associated with EPTB,
treatment failure and increased death rates. HIV testing among TB
patients will facilitate early initiation of HIV care and treatment
services thus reduce the above associated risks.
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Background: The advent of antiretroviral treatment (ART) has
resulted in dramatic reduction in AIDS related morbidity and
mortality. However the emergence and spread of antiretroviral
drug resistance (DR) threatens to negatively impact on treat-
ment regimens and compromise efforts to control the epidemic.
It is recommended that surveillance of drug resistance occur in
conjunction with scale-up efforts to ensure appropriate ﬁrst-line
therapy is offered relative to the resistance that exists. How-
ever standard resistance testing methods used in Subsahara Africa
rely on techniques that miss out on low abundance DR variants
(LADRVs) which have been documented to contribute to treat-
ment failure. The use of next generation sequencing (NGS) has been
shown to be more sensitive for LADRVS. We have carried out a pre-
liminary investigation using NGS to determine the prevalence of
LDRVS among a drug naïve population in North Rift Kenya.
Methods & Materials: Antiretroviral naïve patients attending
a care clinic at Moi Teaching and Referral Hospital (MTRH) in
Eldoret, Kenya were requested and with consent provided blood
samples for DR analysis. DNA was extracted, ampliﬁed and nested
PCR conducted on pol RT region using with primers tagged with
multiplex identiﬁers (MID). Resulting PCR ampliconswere puriﬁed,
quantiﬁed and pyrosequenced using a GS FLX Titanium PicoTiter-
Plate (Roche). Validpyrosequencing readswerealignedwithHXB-2
and the frequency and distribution of nucleotide and amino acid
changes determined using an in-house Perl script. DR mutations
were identiﬁed using the IAS-USA HIV DR mutation database.
Results: Sixty samples were successfully sequence of which 25
were subtype A, 11 subtype D, 1 Subtype C and the remaining were
recombinants. Forty six (76.6%) had at least one drug resistance
mutation; with 25 (41.6%) indicated as major and the rest 21 (35%)
indicated asminor. Themost prevalentmutationwasNRTI position
K219Q/R (11 of 46, 24%) followed byNRTIM184V (5 of 46, 11%) and
NNRTI K103N (4 of 46,9%).
Conclusion: Our use of NGS technology revealed a high preva-
lence of LADRVs among drug naive populations in Kenya. The
impact of these mutations on clinical outcome on ART can only
be ascertain through a long term follow-up.
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